The MERITTM Programme has been developed and funded by Novo Nordisk.
MERIT™ (Meeting Educational Requirements Improving Treatment) is a two-part flexible education programme developed by Novo Nordisk. MERIT™ is a competency-based programme and is for all healthcare professionals involved in diabetes care. The programme combines the theory required to support diabetes management followed by the provision of tailored clinical support from specialist diabetes teams.
This training aims to revise insulin therapy and to address the challenges of managing people with type 2 diabetes on insulin therapy.
This training is delivered in two parts via MS Teams. You must attend both sessions as outlined below:
- Part 1 – 7th December 2021, 12-2pm
- Part 2 – 14th December 2021, 12-2pm
Please click on the link on the right to access the course overview for the full MERIT programme.
Upon booking, your email address will be provided to Novo Nordisk.